je.st
news
Tag: application review
Land Use Review Application (Type III Historic Review)
2015-07-21 00:08:40| PortlandOnline
PDF Document, 5,041kbCategory: Type III Historic Review LUR Application
Tags: type
review
land
application
MM-398 Receiving The Priority Review Designation By US FDA For New Drug Application And The Acceptance Of Market Authorization Application By EMA In Post-Gemcitabine Metastatic Pancreatic Cancer
2015-07-01 08:52:42| drugdiscoveryonline Home Page
PharmaEngine, Inc. (TWO: 4162) announced that (1) its license partner, Merrimack Pharmaceuticals, Inc. (NASDAQ: MACK), has received the notification from the US Food and Drug Administration (FDA) for the acceptance and the grant of the priority review designation for their New Drug Application (NDA); and (2) its sublicense partner, Baxalta Incorporated, a wholly owned subsidiary of Baxter International Inc. (NYSE: BAX) has received the acceptance of Market Authorization Application (MAA) from the European Medicines Agency (EMA), of MM-398 (irinotecan liposome injection, also known as "nal-IRI,") in the treatment of patients with metastatic adenocarcinoma of the pancreas who have been previously treated with gemcitabine-based therapy
Tags: review
market
application
drug
Proposed Washington Park Reservoir Project Type IV Land Use Review Application: City Council Unanimously Approves Application
2015-06-30 22:18:17| PortlandOnline
Tags: type
city
review
project
Proposed Washington Park Reservoir Project Type IV Land Use Review Application: Council Hearing Final Decision Scheduled for June 10
2015-05-27 19:39:56| PortlandOnline
April 14, 2015: Proposed Washington Park Reservoir Project Initial Land Use Review Application: City Council Hearing Scheduled for April 23, Public Comments Accepted
2015-04-14 19:28:04| PortlandOnline
Tags: comments
city
public
april